Prospective birth cohort studies tracking asthma initiation and consolidation in community cohorts have identified viral infections occurring against a background of allergic sensitization to aeroallergens as a uniquely potent risk factor for the expression of acute severe asthma-like symptoms and for the ensuing development of asthma that can persist through childhood and into adulthood. A combination of recent experimental and human studies have suggested that underlying this bipartite process are a series of interactions between antiviral and atopic inflammatory pathways that are mediated by local activation of myeloid cell populations in the airway mucosa and the parallel programming and recruitment of their replacements from bone marrow. Targeting key components of these pathways at the appropriate stages of asthma provides new opportunities for the treatment of established asthma but, more crucially, for primary and secondary prevention of asthma during childhood.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Communications Biology Open Access 04 May 2022
BMC Infectious Diseases Open Access 12 March 2022
Allergy, Asthma & Clinical Immunology Open Access 21 April 2021
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Busse, W.W. & Lemanske, R.F. Asthma. N. Engl. J. Med. 344, 350–362 (2001).
Busse, W.W. The relationship between viral infections and onset of allergic diseases and asthma. Clin. Exp. Allergy 19, 1–9 (1989).
Copenhaver, C.C. et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am. J. Respir. Crit. Care Med. 170, 175–180 (2004).
Stern, D.A., Morgan, W., Wright, A., Guerra, S. & Martinez, F. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370, 758–764 (2007).
Holt, P. et al. Towards improved prediction of risk for atopy and asthma amongst preschoolers: a prospective cohort study. J. Allergy Clin. Immunol. 125, 653–659 (2010).
Oddy, W.H., de Klerk, N.H., Sly, P.D. & Holt, P.G. The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur. Respir. J. 19, 899–905 (2002).
Illi, S. et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. Br. Med. J. 322, 390–395 (2001).
Sly, P.D. et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 372, 1100–1106 (2008).
Jackson, D.J. et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am. J. Respir. Crit. Care Med. 185, 281–285 (2012).
Jackson, D.J. et al. Allergic sensitization is a risk factor for rhinovirus wheezing illnesses during early childhood. J. Allergy Clin. Immunol. 125, AB116 (2010).
Olenec, J.P. et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J. Allergy Clin. Immunol. 125, 1001–1006 (2010).
Martinez, F.D. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc. Am. Thorac. Soc. 2, 157–161 (2005).
Rakes, G.P. et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am. J. Respir. Crit. Care Med. 159, 785–790 (1999).
Bochkov, Y.A. et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat. Med. 17, 627–632 (2011).
Wu, P. et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am. J. Respir. Crit. Care Med. 178, 1123–1129 (2008).
Stein, R.T. & Martinez, F.D. Respiratory syncytial virus and asthma: still no final answer. Thorax 65, 1033–1034 (2010).
Hollams, E.M. et al. Elucidation of asthma phenotypes in atopic teenagers through parallel immunophenotypic and clinical profiling. J. Allergy Clin. Immunol. 124, 463–470 (2009).
Wood, L.J. et al. Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am. J. Respir. Crit. Care Med. 166, 883–889 (2002).
Miller, E.K. et al. A mechanistic role for type III interferon-l1 in asthma exacerbations mediated by human rhinoviruses. Am. J. Respir. Crit. Care Med. 185, 508–516 (2012).
Johnston, S.L. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc. Am. Thorac. Soc. 4, 267–270 (2007).
Wark, P.A.B. et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937–947 (2005).
Contoli, M. et al. Role of deficient type III interferon-l production in asthma exacerbations. Nat. Med. 12, 1023–1026 (2006).
Holt, P.G., Strickland, D.H., Wikstrom, M.E. & Jahnsen, F.L. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8, 142–152 (2008).
Smit, J.J., Rudd, B.D. & Lukacs, N.W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203, 1153–1159 (2006).
de Heer, H.J. et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89–98 (2004).
McWilliam, A.S., Marsh, A.M. & Holt, P.G. Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: involvement of epithelial dendritic cells. J. Virol. 71, 226–236 (1997).
Beyer, M. et al. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J. Allergy Clin. Immunol. 113, 127–133 (2004).
Gill, M.A. et al. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J. Infect. Dis. 191, 1105–1115 (2005).
Kim, E.Y. et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633–640 (2008).
Pechkovsky, D.V. et al. Alternatively activated alveolar macrophages in pulmonary fibrosis–mediator production and intracellular signal transduction. Clin. Immunol. 137, 89–101 (2010).
Cheung, D.S. et al. Cutting edge: CD49d+ neutrophils induce FceRI expression on lung dendritic cells in a mouse model of postviral asthma. J. Immunol. 185, 4983–4987 (2010).
Grayson, M.H. et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J. Exp. Med. 204, 2759–2769 (2007).
Al-Garawi, A. et al. Shifting of immune responsiveness to house dust mite by influenza A infection: genomic insights. J. Immunol. 188, 832–843 (2012).
Subrata, L.S. et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J. Immunol. 183, 2793–2800 (2009).
Blussé van Oud Alblas, A., van der Linden-Schrever, B. & van Furth, R. Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intravenous administration of heat-killed bacillus Calmette-Guerin. J. Exp. Med. 154, 235–252 (1981).
Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23–35 (2003).
Robays, L.J. et al. Chemokine receptor CCR2 but not CCR5 or CCR6 mediates the increase in pulmonary dendritic cells during allergic airway inflammation. J. Immunol. 178, 5305–5311 (2007).
Di Rosa, F. & Pabst, R. The bone marrow: a nest for migratory memory T cells. Trends Immunol. 26, 360–366 (2005).
Cavanagh, L.L. et al. Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nat. Immunol. 6, 1029–1037 (2005).
Hermesh, T., Moltedo, B., Moran, T.M. & Lopez, C.B. Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe 7, 343–353 (2010).
Sihra, B.S., Kon, O.M., Grant, J.A. & Kay, A.B. Expression of high-affinity IgE receptors (Fc e RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J. Allergy Clin. Immunol. 99, 699–706 (1997).
Kraft, S. & Kinet, J.P. New developments in FceRI regulation, function and inhibition. Nat. Rev. Immunol. 7, 365–378 (2007).
Novak, N. et al. Evidence for a differential expression of the Fcε RIγ chain in dendritic cells of atopic and nonatopic donors. J. Clin. Invest. 111, 1047–1056 (2003).
Maurer, D. et al. Peripheral blood dendritic cells express Fc e RI as a complex composed of Fc e RI a- and Fc e RI g-chains and can use this receptor for IgE-mediated allergen presentation. J. Immunol. 157, 607–616 (1996).
Novak, N., Kraft, S. & Bieber, T. Unraveling the mission of FceRI on antigen-presenting cells. J. Allergy Clin. Immunol. 111, 38–44 (2003).
Koraka, P. et al. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J. Med. Virol. 70, 91–98 (2003).
Weber, K.S. et al. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur. J. Immunol. 31, 2458–2466 (2001).
Bosco, A., Ehteshami, S., Stern, D.A. & Martinez, F.D. Decreased activation of inflammatory networks during acute asthma exacerbations is associated with chronic airflow obstruction. Mucosal Immunol. 3, 399–409 (2010).
Gill, M.A. et al. Counterregulation between the FceRI pathway and antiviral responses in human plasmacytoid dendritic cells. J. Immunol. 184, 5999–6006 (2010).
Gauvreau, G.M. & Denburg, J.A. Hemopoietic progenitors: the role of eosinophil/basophil progenitors in allergic airway inflammation. Expert Rev. Clin. Immunol. 1, 87–101 (2005).
Semper, A.E. et al. Surface expression of Fc e RI on Langerhans' cells of clinically uninvolved skin is associated with disease activity in atopic dermatitis, allergic asthma, and rhinitis. J. Allergy Clin. Immunol. 112, 411–419 (2003).
Ker, J. & Hartert, T.V. The atopic march: what's the evidence? Ann. Allergy Asthma Immunol. 103, 282–289 (2009).
Demehri, S., Morimoto, M., Holtzman, M.J. & Kopan, R. Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol. 7, e1000067 (2009).
Zhang, Z. et al. Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proc. Natl. Acad. Sci. USA 106, 1536–1541 (2009).
Siracusa, M.C. et al. TSLP promotes interleukin-3–independent basophil haematopoiesis and type 2 inflammation. Nature 477, 229–233 (2011).
Bisgaard, H. et al. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl. J. Med. 357, 1487–1495 (2007).
Hilty, M. et al. Disordered microbial communities in asthmatic airways. PLoS ONE 5, e8578 (2010).
Huang, Y.J. et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J. Allergy Clin. Immunol. 127, 372–381 (2011).
Hales, B.J. et al. Differences in the antibody response to a mucosal bacterial antigen between allergic and non-allergic subjects. Thorax 63, 221–227 (2008).
Hales, B.J. et al. Antibacterial antibody responses associated with the development of asthma in house dust mite-sensitised and non-sensitised children. Thorax 67, 321–327 (2012).
Hales, B.J. et al. IgE and IgG anti–house dust mite specificities in allergic disease. J. Allergy Clin. Immunol. 118, 361–367 (2006).
Talbot, T.R. et al. Asthma as a risk factor for invasive pneumococcal disease. N. Engl. J. Med. 352, 2082–2090 (2005).
Klemets, P. et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 65, 698–702 (2010).
Hollams, E.M. et al. Th2-associated immunity to bacteria in asthma in teenagers and susceptibility to asthma. Eur. Respir. J. 36, 509–516 (2010).
Choy, D.F. et al. Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J. Immunol. 186, 1861–1869 (2011).
Moore, W.C. et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 181, 315–323 (2010).
Busse, W.W. et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl. J. Med. 364, 1005–1015 (2011).
Razi, C.H. et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J. Allergy Clin. Immunol. 126, 763–769 (2010).
Navarro, S. et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol. 4, 53–65 (2011).
Strickland, D.H. et al. Boosting airway mucosal T-regulatory cell defenses via gastrointestinal microbial stimulation: a potential therapeutic strategy for asthma control. Mucosal Immunol. 4, 43–52 (2011).
Shaaban, R. et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 372, 1049–1057 (2008).
Sherrill, D.L., Guerra, S., Minervini, M.C., Wright, A.L. & Martinez, F.D. The relation of rhinitis to recurrent cough and wheezing: a longitudinal study. Respir. Med. 99, 1377–1385 (2005).
Jacobsen, L. et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62, 943–948 (2007).
Nelson, D.J., McWilliam, A.S., Haining, S. & Holt, P.G. Modulation of airway intraepithelial dendritic cells following exposure to steroids. Am. J. Respir. Crit. Care Med. 151, 475–481 (1995).
Martinez, F.D. Asthma treatment and asthma prevention: a tale of 2 parallel pathways. J. Allergy Clin. Immunol. 119, 30–33 (2007).
Hibbert, M.E., Hudson, I.L., Lanigan, A., Landau, L.I. & Phelan, P.D. Tracking of lung function in healthy children and adolescents. Pediatr. Pulmonol. 8, 172–177 (1990).
Hopper, J.L., Hibbert, M.E., Macaskill, G.T., Phelan, P.D. & Landau, L.I. Longitudinal analysis of lung function growth in healthy children and adolescents. J. Appl. Physiol. 70, 770–777 (1991).
Larsen, G.L. & Colasurdo, G.N. Neural control mechansims within airways: disruption by respiratory syncytial virus. J. Pediatr. 135, 21–27 (1999).
Sly, P.D. & Flack, F. Susceptibility of children to environmental pollutants. Ann. NY Acad. Sci. 1140, 163–183 (2008).
Soto-Martinez, M. & Sly, P.D. Relationship between environmental exposures in children and adult lung disease: the case for outdoor exposures. Chron. Respir. Dis. 7, 173–186 (2010).
O'Byrne, P.M., Pedersen, S., Lamm, C., Tan, W. & Busse, W. Severe exacerbations and decline in lung function in asthma. Am. J. Respir. Crit. Care Med. 179, 19–24 (2009).
Holgate, S.T. The airway epithelium is central to the pathogenesis of asthma. Allergol. Int. 57, 1–10 (2008).
Lloyd, C.M. & Saglani, S. Asthma and allergy: the emerging epithelium. Nat. Med. 16, 273–274 (2010).
Simoes, E.A. et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J. Pediatr. 151, 34–42 (2007).
de Vrese, M. et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24, 6670–6674 (2006).
Collet, J.P. et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am. J. Respir. Crit. Care Med. 156, 1719–1724 (1997).
Tandon, M.K. et al. Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD. Chest 137, 805–811 (2010).
Schaad, U.B., Mutterlein, R. & Goffin, H. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 122, 2042–2049 (2002).
Gao, L. et al. A randomized controlled trial of low-dose recombinant human interferons a-2b nasal spray to prevent acute viral respiratory infections in military recruits. Vaccine 28, 4445–4451 (2010).
Wenzel, S., Wilbraham, D., Fuller, R., Getz, E.B. & Longphre, M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370, 1422–1431 (2007).
Buhl, R. et al. Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. Eur. Respir. J. 20, 73–78 (2002).
Solèr, M. et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur. Respir. J. 18, 254–261 (2001).
Durham, S.R. Sublingual immunotherapy: what have we learnt from the 'big trials'? Curr. Opin. Allergy Clin. Immunol. 8, 577–584 (2008).
Corren, J. et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088–1098 (2011).
The authors declare no competing financial interests.
About this article
Cite this article
Holt, P., Sly, P. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 18, 726–735 (2012). https://doi.org/10.1038/nm.2768
This article is cited by
BMC Infectious Diseases (2022)
Communications Biology (2022)
Allergy, Asthma & Clinical Immunology (2021)
DP1 prostanoid receptor activation increases the severity of an acute lower respiratory viral infection in mice via TNF-α-induced immunopathology
Mucosal Immunology (2021)
Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma
Nature Communications (2020)